Future research in ITP: an ICIS consensus

Research output: Contribution to journalArticle


While much has been learned about the basic immunology and clinical characteristics of immune thrombocytopenia, many important questions remain with regard to pathogenesis, disease progression, identification of novel therapeutic targets and approaches, and clinical trials that rationalize and optimize use of existing therapies. The answers to these questions are likely to impact our understanding of the pathogenesis and therapeutic targets of autoimmune disease in general.


  • James L Zehnder
  • John W Semple
  • Paul Imbach
  • Ellis J Neufeld
  • George R Buchanan
  • Douglas B Cines
  • ICIS Study Group on Future Research in ITP
External organisations
  • University of Toronto
Research areas and keywords


  • Adult, Age Factors, Animals, Child, Disease Models, Animal, Disease Progression, Helicobacter Infections, Helicobacter pylori, Humans, Molecular Targeted Therapy, Purpura, Thrombocytopenic, Idiopathic, Journal Article
Original languageEnglish
Pages (from-to)19-23
Number of pages5
JournalAnnals of Hematology
Issue numberSuppl 1
Publication statusPublished - 2010 Jul
Publication categoryResearch
Externally publishedYes